nach oben

Pathology & Oncology Research

Erschienen in:

20.03.2019 | Original Article

Anti-Estrogenic and Anti-Cell Proliferative Effect of Allyl Isothiocyanate in Chemoprevention of Chemically Induced Mammary Carcinogenesis in Rats

verfasst von: Rajakumar Thangarasu, Pugalendhi Pachaiappan, Thilagavathi Subbaiyan

Erschienen in: Pathology & Oncology Research | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

The anti-estrogenic and anti-cell proliferative effect of allyl isothiocyanate (AITC) was carried out by analyzing the status of sex hormones and its receptors and cell proliferative markers in chemically induced mammary carcinogenesis in rats. Mammary tumor was induced by a single dose of DMBA (25 mg/rat) and MNU (50 mg/kg bw) injected subcutaneously near mammary gland. RT-PCR, western blotting and immunohistochemical analysis of mammary tissues show an upregulation of ER-α, PR, aromatase, PCNA, cyclin D1 and AgNORs staining and down regulation of p53 expression as well as plasma estradiol, prolactin and testosterone levels increased in DMBA and MNU-induced tumor bearing rats. Oral administration of AITC at a dose of 20 mg/kg bw restored the levels of sex hormones and its receptors, aromatase, cell proliferative markers and AgNORs staining near to normal levels. Molecular docking studies also supported these findings. The results suggest that anti-estrogenic and anti-proliferative effect of AITC prevent the development of DMBA and MNU-induced mammary carcinogenesis in rat.

Siegel R, Ma J, Zou Z, Jemal A (2014) Cancer statistics. CA Cancer J Clin 64:9–29PubMedCrossRef

Yager JD, Davidson NE (2006) Estrogen carcinogenesis in breast cancer. N Engl J Med 354:270–282PubMedCrossRef

Mirzaie S, Chupani L, Asadabadi EB, Shahverdi AR, Jamalan M (2013) Novel inhibitor discovery against aromatase through virtual screening and molecular dynamic simulation: a computational approach in drug design. EXCLI J 12:168–183PubMedPubMedCentral

Mense SM, Remotti F, Bhan A, Singh B, El-Tamer M, Hei TK, Bhat HK (2008) Estrogen-induced breast cancer: alterations in breast morphology and oxidative stress as a function of estrogen exposure. Toxicol Appl Pharmacol 232:78–85PubMedPubMedCentralCrossRef

Mertani HC, Garcia-Caballero T, Lambert A, Gérard F, Palayer C, Boutin JM, Vonderhaar BK, Waters MJ, Lobie PE, Morel G (1998) Cellular expression of growth hormone and prolactin receptors in human breast disorders. Int J Cancer 79:202–211PubMedCrossRef

Storer RD, Kraynak AR, Mckelvey TW, Elia MC, Goodrow TL, Deluca JQ (1997) The mouse lymphoma L5178Y TK+/− cell line is heterozygous for a codon 170 mutation in the p53 tumor suppressor gene. Mutat Res 373:157–165PubMedCrossRef

Kasala ER, Bodduluru LN, Madana RM, Athira KV, Gogoi R, Barua CC (2015) Chemopreventive and therapeutic potential of chrysin in cancer: mechanistic perspectives. Toxicol Lett 233:214–225PubMedCrossRef

Caldon CE, Sutherland RL, Musgrove E (2010) Cell cycle proteins in epithelial cell differentiation: implications for breast cancer. Cell Cycle 9:1918–1928PubMedCrossRef

Arivazhagan L, Sorimuthu Pillai S (2014) Tangeretin, a citrus pentamethoxyflavone, exerts cytostatic effect via p53/p21 up-regulation and suppresses metastasis in 7,12-dimethylbenz(α)anthracene-induced rat mammary carcinoma. J Nutr Biochem 25:1140–1153PubMedCrossRef

10.

Allred CD, Allred KF, Ju YH, Clausen LM, Doerge DR, Schantz SL, Korol DL, Wallig MA, Helferich WG (2004) Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats. Carcinogenesis 25:211–218PubMedCrossRef

11.

Kwon KH, Barve A, Yu S, Huang MT, Kong AN (2007) Cancer chemoprevention by phytochemicals: potential molecular targets, biomarkers and animal models. Acta Pharmacol Sin 28:1409–1421PubMedCrossRef

12.

Wattenberg LW (1987) Inhibitory effects of benzyl isothiocyanates administered shortly before diethylnitrosamine or benzo[a]pyrene on pulmonary and forestomach neoplasia in A/J mice. Carcinogenesis 8:1971–1973PubMedCrossRef

13.

Xiao D, Srivastava SK, Lew KL, Zeng Y, Hershberger P, Johnson CS, Trump DL, Singh SV (2003) Allyl isothiocyanate, a constituent of cruciferous vegetables, inhibits proliferation of human prostate cancer cells by causing G2/M arrest and inducing apoptosis. Carcinogenesis 24:891–897PubMedCrossRef

14.

Rajakumar T, Pugalendhi P, Thilagavathi S (2015) Dose response chemopreventive potential of allyl isothiocyanate against 7,12-dimethylbenz(a)anthracene induced mammary carcinogenesis in female Sprague-Dawley rats. Chem Biol Interact 231:35–43PubMedCrossRef

15.

Ploton D, Menager M, Jeannesson P, Himber G, Pigeon F, Adnet JJ (1986) Improvement in the staining and in the visualization of the argyrophilic proteins of the nucleolar organizer region at the optical level. Histochem J 18:5–14PubMedCrossRef

16.

Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156–159PubMedCrossRef

17.

Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with Folin phenol reagent. J Biol Chem 193:265–275PubMed

18.

Santen RJ, Allred DC, Ardoin SP, Archer DF, Boyd N, Braunstein GD, Burger HG, Colditz GA, Davis SR, Gambacciani M, Gower BA, Henderson VW, Jarjour WN, Karas RH, Kleerekoper M, Lobo RA, Manson JE, Marsden J, Martin KA, Martin L, Pinkerton JV, Rubinow DR, Teede H, Thiboutot DM, Utian WH, Endocrine Society (2010) Postmenopausal hormone therapy: an Endocrine Society scientific statement. J Clin Endocrinol Metab 95:S1–S66PubMedPubMedCentralCrossRef

19.

el-Aziz MA, Hassan HA, Mohamed MH, Meki AR, Abdel-Ghaffar SK, Hussein MR (2005) The biochemical and morphological alterations following administration of melatonin, retinoic acid and Nigella sativa in mammary carcinoma: an animal model. Int J Exp Pathol 86:383–396PubMedPubMedCentralCrossRef

20.

Lakshmi A, Subramanian S (2014) Chemotherapeutic effect of tangeretin, a polymethoxylated flavone studied in 7,12-dimethylbenz(a)anthracene induced mammary carcinoma in experimental rats. Biochimie 99:96–109PubMedCrossRef

21.

Kang L, Ding L, Wang ZY (2009) Isothiocyanates repress estrogen receptor alpha expression in breast cancer cells. Oncol Rep 21:185–192PubMed

22.

Powers CN, Setzer WN (2015) A molecular docking study of phytochemical estrogen mimics from dietary herbal supplements. In Silico Pharmacol 3:4PubMedPubMedCentralCrossRef

23.

Clevenger CV, Furth PA, Hankinson SE, Schuler LA (2003) The role of prolactin in mammary carcinoma. Endocr Rev 24:1–27PubMedCrossRef

24.

Cos S, González A, Güezmes A, Mediavilla MD, Martínez-Campa C, Alonso-González C, Sánchez-Barceló EJ (2006) Melatonin inhibits the growth of DMBA-induced mammary tumors by decreasing the local biosynthesis of estrogens through the modulation of aromatase activity. Int J Cancer 118:274–278PubMedCrossRef

25.

Brueggemeier RW, Hackett JC, Diaz-Cruz ES (2005) Aromatase inhibitors in the treatment of breast cancer. Endocr Rev 26:331–345PubMedCrossRef

26.

Munusami P, Vasavi CS, Divya G (2014) Molecular docking studies on flavonoid compounds: an insight into aromatase inhibitors. Int J Pharm Pharm Sci 6:141–148

27.

Al-Dhaheri WS, Hassouna I, Al-Salam S, Karam SM (2008) Characterization of breast cancer progression in the rat. Ann N Y Acad Sci 1138:121–131PubMedCrossRef

28.

Derenzini M, Ploton D (1991) Interphase nucleolar organizer regions in cancer cells. Int Rev Exp Pathol 32:149–192PubMedCrossRef

29.

Derenzini M, Pession A, Trerè D (1990) Quantity of nucleolar silver-stained proteins is related to proliferating activity in cancer cells. Lab Investig 63:137–140PubMed

30.

Agarwal ML, Agarwal A, Taylor WR, Stark GR (1995) p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc Natl Acad Sci U S A 92:8493–8497PubMedPubMedCentralCrossRef

31.

Tor YS, Yazan LS, Foo JB, Wibowo A, Ismail N, Cheah YK, Abdullah R, Ismail M, Ismail IS, Yeap SK (2015) Induction of apoptosis in MCF-7 cells via oxidative stress generation, mitochondria-dependent and caspase-independent pathway by ethyl acetate extract of Dillenia suffruticosa and its chemical profile. PLoS One 10:e0127441PubMedPubMedCentralCrossRef

32.

Chen NG, Chen KT, Lu CC, Lan YH, Lai CH, Chung YT, Yang JS, Lin YC (2010) Allyl isothiocyanate triggers G2/M phase arrest and apoptosis in human brain malignant glioma GBM 8401 cells through a mitochondria-dependent pathway. Oncol Rep 24:449–455PubMed

33.

Rengarajan T, Nandakumar N, Balasubramanian MP (2013) D-Pinitol prevents rat breast carcinogenesis induced by 7, 12-Dimethylbenz [a] anthracene through inhibition of Bcl-2 and induction of p53, caspase-3 proteins and modulation of hepatic biotransformation enzymes and antioxidants. Biomed Prev Nutr 3:31–41CrossRef

34.

Gowtham Kumar S, Ramakrishnan V, Madhusudhanan N, Thiyagarajan G, Langeswaran VK, Balasubramanian MP (2011) Apoptosis induced in hepatoma cells (hepg2) by allyl isothiocyanate associated with expression of p53 and activation of caspase-3. IJBPR 2:19–26

35.

Yang YM, Conaway CC, Chiao JW, Wang CX, Amin S, Whysner J, Dai W, Reinhardt J, Chung FL (2002) Inhibition of benzo(a)pyrene-induced lung tumorigenesis in a/J mice by dietary N-acetylcysteine conjugates of benzyl and phenethyl isothiocyanates during the postinitiation phase is associated with activation of mitogen-activated protein kinases and p53 activity and induction of apoptosis. Cancer Res 62:2–7PubMed

36.

Bishayee A, Mandal A (2014) Trianthema portulacastrum Linn. Exerts chemoprevention of 7,12-dimethylbenz(a)anthracene-induced mammary tumorigenesis in rats. Mutat Res 768:107–118PubMedCrossRef

37.

Rajmani RS, Doley J, Singh PK, Kumar R, Barathidasan R, Kumar P, Verma PC, Tiwari AK (2011) Induction of mammary gland tumour in rats using N-methyl-N-nitroso urea and their histopathology. Indian J Vet Pathol 35:142–146

38.

Yu Q, Geng Y, Sicinski P (2001) Specific protection against breast cancers by cyclin D1 ablation. Nature 411:1017–1021PubMedCrossRef

39.

Jang TJ, Kang MS, Kim H, Kim DH, Lee JI, Kim JR (2000) Increased expression of cyclin D1, cyclin E and p21(Cip1) associated with decreased expression of p27(Kip1) in chemically induced rat mammary carcinogenesis. Jpn J Cancer Res 91:1222–1232PubMedPubMedCentralCrossRef

40.

Ashrafi M, Bathaie SZ, Abroun S (2012) High expression of cyclin D1 and p21 in N-Nitroso-N-Methylurea-induced breast Cancer in Wistar albino female rats. Cell J Fall 14:193–202

41.

Chiao JW, Chung FL, Kancherla R, Ahmed T, Mittelman A, Conaway CC (2002) Sulforaphane and its metabolite mediate growth arrest and apoptosis in human prostate cancer cells. Int J Oncol 20:631–636PubMed

Titel: Anti-Estrogenic and Anti-Cell Proliferative Effect of Allyl Isothiocyanate in Chemoprevention of Chemically Induced Mammary Carcinogenesis in Rats
verfasst von: Rajakumar Thangarasu
Pugalendhi Pachaiappan
Thilagavathi Subbaiyan
Publikationsdatum: 20.03.2019
Verlag: Springer Netherlands
Erschienen in: Pathology & Oncology Research / Ausgabe 2/2020
Print ISSN: 1219-4956
Elektronische ISSN: 1532-2807
DOI: https://doi.org/10.1007/s12253-019-00638-9

Springer Medizin

Anti-Estrogenic and Anti-Cell Proliferative Effect of Allyl Isothiocyanate in Chemoprevention of Chemically Induced Mammary Carcinogenesis in Rats

Abstract

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2020

miR-370 Sensitizes TMZ Response Dependent of MGMT Status in Primary Central Nervous System Lymphoma

Silencing UHRF1 Inhibits Cell Proliferation and Promotes Cell Apoptosis in Retinoblastoma Via the PI3K/Akt Signalling Pathway

Epstein-Barr Virus MicroRNAs in Nasopharyngeal Carcinoma

The Small Bowel Cancer Incidence Enigma

lncRNA SNHG16 Exerts Oncogenic Functions in Promoting Proliferation of Glioma Through Suppressing p21

Solid-pseudopapillary Neoplasms of the Pancreas is still an Enigma: a Clinicopathological Review

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie